This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Beijing Hanmi Pharmaceutical Co., Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Shusen Xu: Innovator in Pharmaceutical Compositions
Introduction
Shusen Xu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing therapeutic options for patients through novel analogs.
Latest Patents
Shusen Xu holds a patent for "Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof." This invention provides a GIP analog derived from GIP (1-29, SEQ ID NO: 1), which exhibits both GLP-1 agonist activity and GIPR stimulation activity. The amino acid sequence of the GIP analog is represented by the formula I: Tyr-A2-A3-Gly-Thr-Phe-A7-Ser-Asp-Tyr-Ser-A12-A13-A14-A15-Lys-A17-A18-A19-A20-A21-A22-A23-A24-Trp-Leu-A27-A28-A29-Y. Additionally, the invention includes a pharmaceutical composition comprising the GIP analog and its various uses.
Career Highlights
Shusen Xu is currently associated with Beijing Hanmi Pharmaceutical Co., Ltd. His role in the company has allowed him to focus on research and development in the pharmaceutical sector. His innovative approach has led to advancements in drug formulations that can potentially improve patient outcomes.
Collaborations
Shusen Xu has collaborated with notable colleagues, including Wei Zhang and Ning Shen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Shusen Xu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options that can benefit patients worldwide.